GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.UN) » Definitions » 3-Month Share Buyback Ratio

DRI Healthcare Trust (TSX:DHT.UN) 3-Month Share Buyback Ratio : -0.01% (As of Mar. 2025 )


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. DRI Healthcare Trust's current 3-Month Share Buyback Ratio was -0.01%.

Competitive Comparison of DRI Healthcare Trust's 3-Month Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DRI Healthcare Trust's 3-Month Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's 3-Month Share Buyback Ratio falls into.


;
;

DRI Healthcare Trust 3-Month Share Buyback Ratio Calculation

DRI Healthcare Trust's 3-Month Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Dec. 2024 ) - Shares Outstanding (EOP) (Mar. 2025 )) / Shares Outstanding (EOP) (Dec. 2024 )
=(56.304 - 56.311) / 56.304
=-0.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DRI Healthcare Trust  (TSX:DHT.UN) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

DRI Healthcare Trust 3-Month Share Buyback Ratio Related Terms

DRI Healthcare Trust Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.UN) » Definitions » 3-Month Share Buyback Ratio
Comparable Companies
TSX:CURA NEOE:GLAS.A.U TSX:GUD XCNQ:VREO XCNQ:TRUL TSX:CRON TSX:CPH TSX:ACB TSX:WEED TSX:OGI ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
DHTRF:USA 3IJ0:Germany DHT.U:Canada
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
Website
https://www.dricapital.com
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically the trust generates it's key revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

DRI Healthcare Trust Headlines

No Headlines